Cargando…
Erythrocytes Induce Vascular Dysfunction in COVID-19
Current knowledge regarding mechanisms underlying cardiovascular complications in patients with COVID-19 is limited and urgently needed. We shed light on a previously unrecognized mechanism and unravel a key role of red blood cells, driving vascular dysfunction in patients with COVID-19 infection. W...
Autores principales: | Mahdi, Ali, Collado, Aida, Tengbom, John, Jiao, Tong, Wodaje, Tigist, Johansson, Niclas, Farnebo, Filip, Färnert, Anna, Yang, Jiangning, Lundberg, Jon O., Zhou, Zhichao, Pernow, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849181/ https://www.ncbi.nlm.nih.gov/pubmed/35194565 http://dx.doi.org/10.1016/j.jacbts.2021.12.003 |
Ejemplares similares
-
Erythrocytes induce vascular dysfunction in COVID-19
por: Mahdi, A, et al.
Publicado: (2021) -
Stimulation of Erythrocyte Soluble Guanylyl Cyclase Induces cGMP Export and Cardioprotection in Type 2 Diabetes
por: Jiao, Tong, et al.
Publicado: (2023) -
The red blood cell as a mediator of endothelial dysfunction in patients with familial hypercholesterolemia and dyslipidemia
por: Mahdi, Ali, et al.
Publicado: (2022) -
Erythrocytes Induce Endothelial Injury in Type 2 Diabetes Through Alteration of Vascular Purinergic Signaling
por: Mahdi, Ali, et al.
Publicado: (2020) -
Erythrocytes from patients with ST-elevation myocardial infarction induce cardioprotection through the purinergic P2Y(13) receptor and nitric oxide signaling
por: Jiao, Tong, et al.
Publicado: (2022)